What is the equivalent dose of bumetanide (BMX) for furosemide (Lasix) 120 mg twice daily?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Bumetanide Equivalent Dose for Furosemide 120 mg Twice Daily

For furosemide (Lasix) 120 mg twice daily (240 mg total daily dose), the equivalent bumetanide dose is 6 mg daily, typically given as 3 mg twice daily.

Dose Conversion Rationale

The standard conversion ratio between furosemide and bumetanide is 40:1 1, 2, 1. This ratio is consistently supported across multiple guidelines and research studies:

  • Guideline consensus: The 2008 ESC Heart Failure Guidelines explicitly state that 20-40 mg furosemide IV equals 0.5-1 mg bumetanide 1
  • Research validation: A 2013 retrospective study in heart failure patients confirmed a potency ratio of 41:1 for intermittent IV dosing and 34:1 overall, supporting the standard 40:1 conversion 3
  • Clinical practice: The 2013 ACC/AHA Heart Failure Guidelines list bumetanide starting doses of 0.5-1 mg corresponding to furosemide 20-40 mg 2

Calculation

  • Furosemide 240 mg daily ÷ 40 = 6 mg bumetanide daily
  • Typical dosing: 3 mg twice daily (or 6 mg once daily, though twice daily is more common)

Important Clinical Considerations

Bioavailability Differences

Bumetanide has superior oral bioavailability (80-90%) compared to furosemide (10-90%, average ~50%) 4. This means:

  • Oral-to-IV conversion for bumetanide is approximately 1:1 4
  • Oral-to-IV conversion for furosemide is approximately 2:1 4
  • When switching from oral furosemide to oral bumetanide, the 40:1 ratio remains appropriate

Monitoring Requirements

When converting between loop diuretics, monitor closely:

  • Daily weights and urine output in first 48-72 hours
  • Electrolytes and renal function within 5-7 days 5
  • Volume status (orthopnea, edema, jugular venous pressure)
  • Target weight loss: 0.5-1 kg/day without peripheral edema, up to 1 kg/day with edema 4

Dose Titration

  • Maximum bumetanide dose: 10 mg/day orally 2, 6
  • If inadequate response at 6 mg daily, increase by 1-2 mg increments 6
  • Consider adding thiazide (metolazone 2.5-5 mg) for diuretic resistance rather than exceeding maximum doses 1, 2

Potential Advantages of Bumetanide

  • More predictable absorption due to higher bioavailability 7, 8
  • Lower risk of ototoxicity compared to furosemide 7, 8
  • Easier dose titration in patients with gastrointestinal edema affecting absorption 8

Common Pitfalls to Avoid

  1. Don't underdose: Using ratios less than 40:1 may result in inadequate diuresis
  2. Don't forget potassium monitoring: Both drugs cause similar potassium wasting despite bumetanide being more potent 7
  3. Reassess need regularly: The goal is the lowest effective dose to maintain euvolemia 2
  4. Watch for contraction alkalosis: May require acetazolamide addition in refractory cases 4

12137

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.